If you want to know who makes Zepbound and where it comes from, the short answer points to one large American pharmaceutical company and its growing US manufacturing network.
Quick answer: Zepbound is manufactured by Eli Lilly and Company, headquartered in Indianapolis, Indiana. Lilly produces tirzepatide, the active ingredient in both Zepbound and Mounjaro, through a network of manufacturing sites and has invested heavily in US production, including a major facility in Lebanon, Indiana, expected to begin making medicines around late 2026. Tirzepatide is the single active ingredient in Zepbound, which is supplied in single-dose pens and single-dose vials. Lilly uses US and international sites across its manufacturing network.
Who makes Zepbound?
Zepbound is made by Eli Lilly and Company, one of the largest pharmaceutical companies in the world, headquartered in Indianapolis, Indiana. Lilly developed tirzepatide and brought it to market as both Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management and obstructive sleep apnea in adults with obesity). So when people ask who manufactures Zepbound, the answer is Eli Lilly, the same company behind Mounjaro, since both contain the identical active ingredient, tirzepatide.
Is Zepbound made in the USA?
Eli Lilly is a US-based company and produces medicines through a manufacturing network that includes significant US operations. The company has committed billions of dollars to expanding US production capacity for tirzepatide, including a large new site in Lebanon, Indiana, designed to make the tirzepatide active ingredient, which the company expected to begin producing medicines around late 2026. Like most major drugmakers, Lilly also uses additional sites for steps such as fill-finish and packaging. So tirzepatide manufacturing has a strong and growing US footprint, with Indiana at its center.
Where is tirzepatide manufactured?
Tirzepatide, the active ingredient shared by Zepbound and Mounjaro, is produced within Eli Lilly's manufacturing network. The company has been scaling up capacity to meet high demand, with major investment concentrated in Indiana, including the Lebanon site for active-ingredient production. Drug manufacturing typically involves multiple steps and locations, from making the active ingredient to filling devices and packaging, so the full journey of a given pen or vial can span more than one facility within the network. The central point is that Lilly controls and operates this production.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →What is Zepbound made of?
Zepbound's active ingredient is tirzepatide, a single molecule that acts on both GLP-1 and GIP receptors. Beyond the active ingredient, the product contains standard injectable excipients (inactive ingredients) that stabilize the formulation, and it is supplied in sterile single-dose pens and single-dose vials. The exact inactive ingredients are listed in the prescribing information. There is nothing exotic in its makeup; it is a peptide-based injectable medicine produced under pharmaceutical manufacturing standards.
How is Zepbound packaged?
Zepbound is supplied in single-dose formats: prefilled single-dose pens and single-dose vials, with the vial option drawn up using a separate syringe. Single-dose packaging means each unit delivers one dose, which supports sterility and accurate dosing. The medication has specific storage requirements, generally refrigeration with limits on time at room temperature, detailed in the product information. Always follow the storage and handling instructions provided with your specific Zepbound product.
Where does this leave compounded options?
Zepbound is the branded tirzepatide product made by Eli Lilly. Compounded tirzepatide is a separate category, prepared by licensed compounding pharmacies under different rules, not by Lilly. For people seeking a supervised, lower-cost route, FormBlends connects patients with licensed US pharmacies for compounded tirzepatide and semaglutide. See our semaglutide options or compare providers with our provider comparison tool.
Frequently asked questions
Who manufactures Zepbound? Eli Lilly and Company, headquartered in Indianapolis, Indiana.
Is Zepbound made in the USA? Lilly produces it through a network with major US operations, including a large Indiana site for tirzepatide active ingredient.
Where is tirzepatide manufactured? Within Eli Lilly's manufacturing network, with major investment concentrated in Indiana.
What is Zepbound made of? Its active ingredient is tirzepatide, plus standard injectable inactive ingredients, in single-dose pens and vials.
Where is Mounjaro manufactured? Mounjaro is also made by Eli Lilly and contains the active-ingredient equivalence, tirzepatide.
How is Zepbound packaged? In single-dose prefilled pens and single-dose vials, with specific storage requirements.
Is compounded tirzepatide the same as Zepbound? No. Compounded tirzepatide is a separate category from branded Zepbound, made by licensed compounding pharmacies.
Sources
- Eli Lilly Zepbound media kit: https://www.lilly.com/news/media/zepbound
- Eli Lilly Indiana manufacturing investment: https://www.biopharmadive.com/news/lilly-zepbound-manufacturing-invest-indiana-tirzepatide/717108/